ADVERTISEMENT

PH VCO, lagundi, tawa-tawa clinical trials to benefit farmers, says DOST exec

Published Oct 23, 2021 02:58 pm

The country’s clinical trials on the use of virgin coconut oil (VCO), lagundi (Chinese chaste tree) and tawa-tawa (Euphorbia hirta) as adjunct therapy, herbal medicine, and adjunctive treatment against coronavirus disease (COVID-19) may benefit the country’s farmers, the Department of Science and Technology (DOST) said on Saturday, Oct. 23.

vcolagunditawa

DOST Undersecretary for Research and Development (R&D) Rowena Cristina Guevara said the positive results of the clinical trials would mean income for the Filipino farmers.

“Dahil herbal medicine ito nagde-depend pa rin ito sa mga itinanim ng farmers. Kung makakapag-export tayo nitong mga produktong ito ay tataas ang kita ng ating mga farmers na nagtatanim ng tawa-tawa, lagundi at saka syempre coconut. (Because this is herbal medicine, it still depends on what the farmers plant. If we can export these products, this will increase the income of our farmers who grow tawa-tawa, lagundi and of course, the coconut),” she said during the Laging Handa briefing on Saturday.

“Ang ineemphasize lang namin kailangang tamang variety nitong lagundi at tawa-tawa ang gagamitin natin (We just emphasize that we need to grow the right variety of lagundi and tawa tawa).”

Guevara said other countries were taking interest in the country’s clinical studies on the use of VCO, tawa-tawa, and lagundi against COVID.

“Andami naming natatanggap na inquiry kasi gusto nilang magkumpara kung ano ang equivalent dun sa kanilang bansa dito sa ating mga halaman so we have to exchange scientific names, at sila din naman nagbibigay sila sa atin ng mga scientific names ..at inaaral din ng ating researchers (We have received a lot of inquiries because they want to compare what is equivalent in their country here with our plants so we have to exchange scientific names, and they also give us scientific names ..and our researchers study them).”

Guevara had bared that using VCO, lagundi and tawa-tawa for coronavirus disease (COVID-19) patients yielded positive results.

READ MORE: https://mb.com.ph/2021/10/18/lagundi-as-herbal-medicine-reduces-symptoms-of-mild-covid-patients-dost/

https://mb.com.ph/2021/10/18/tawa-tawa-extract-for-mild-moderate-covid-patients-can-work-wonders-says-dost-exec/

https://mb.com.ph/2021/10/17/is-vco-an-effective-adjunct-therapy-for-hospitalized-covid-19-patients/

Related Tags

rowena guevara vco tawa tawa clinical trial tawa-tawa LAGUNDI VCO CLINICAL TRIALS DOST Lagundi clinical trials
ADVERTISEMENT
.most-popular .layout-ratio{ padding-bottom: 79.13%; } @media (min-width: 768px) and (max-width: 1024px) { .widget-title { font-size: 15px !important; } }

{{ articles_filter_1561_widget.title }}

.most-popular .layout-ratio{ padding-bottom: 79.13%; } @media (min-width: 768px) and (max-width: 1024px) { .widget-title { font-size: 15px !important; } }

{{ articles_filter_1562_widget.title }}

.most-popular .layout-ratio{ padding-bottom: 79.13%; } @media (min-width: 768px) and (max-width: 1024px) { .widget-title { font-size: 15px !important; } }

{{ articles_filter_1563_widget.title }}

{{ articles_filter_1564_widget.title }}

.mb-article-details { position: relative; } .mb-article-details .article-body-preview, .mb-article-details .article-body-summary{ font-size: 17px; line-height: 30px; font-family: "Libre Caslon Text", serif; color: #000; } .mb-article-details .article-body-preview iframe , .mb-article-details .article-body-summary iframe{ width: 100%; margin: auto; } .read-more-background { background: linear-gradient(180deg, color(display-p3 1.000 1.000 1.000 / 0) 13.75%, color(display-p3 1.000 1.000 1.000 / 0.8) 30.79%, color(display-p3 1.000 1.000 1.000) 72.5%); position: absolute; height: 200px; width: 100%; bottom: 0; display: flex; justify-content: center; align-items: center; padding: 0; } .read-more-background a{ color: #000; } .read-more-btn { padding: 17px 45px; font-family: Inter; font-weight: 700; font-size: 18px; line-height: 16px; text-align: center; vertical-align: middle; border: 1px solid black; background-color: white; } .hidden { display: none; }
function initializeAllSwipers() { // Get all hidden inputs with cms_article_id document.querySelectorAll('[id^="cms_article_id_"]').forEach(function (input) { const cmsArticleId = input.value; const articleSelector = '#article-' + cmsArticleId + ' .body_images'; const swiperElement = document.querySelector(articleSelector); if (swiperElement && !swiperElement.classList.contains('swiper-initialized')) { new Swiper(articleSelector, { loop: true, pagination: false, navigation: { nextEl: '#article-' + cmsArticleId + ' .swiper-button-next', prevEl: '#article-' + cmsArticleId + ' .swiper-button-prev', }, }); } }); } setTimeout(initializeAllSwipers, 3000); const intersectionObserver = new IntersectionObserver( (entries) => { entries.forEach((entry) => { if (entry.isIntersecting) { const newUrl = entry.target.getAttribute("data-url"); if (newUrl) { history.pushState(null, null, newUrl); let article = entry.target; // Extract metadata const author = article.querySelector('.author-section').textContent.replace('By', '').trim(); const section = article.querySelector('.section-info ').textContent.replace(' ', ' '); const title = article.querySelector('.article-title h1').textContent; // Parse URL for Chartbeat path format const parsedUrl = new URL(newUrl, window.location.origin); const cleanUrl = parsedUrl.host + parsedUrl.pathname; // Update Chartbeat configuration if (typeof window._sf_async_config !== 'undefined') { window._sf_async_config.path = cleanUrl; window._sf_async_config.sections = section; window._sf_async_config.authors = author; } // Track virtual page view with Chartbeat if (typeof pSUPERFLY !== 'undefined' && typeof pSUPERFLY.virtualPage === 'function') { try { pSUPERFLY.virtualPage({ path: cleanUrl, title: title, sections: section, authors: author }); } catch (error) { console.error('ping error', error); } } // Optional: Update document title if (title && title !== document.title) { document.title = title; } } } }); }, { threshold: 0.1 } ); function showArticleBody(button) { const article = button.closest("article"); const summary = article.querySelector(".article-body-summary"); const body = article.querySelector(".article-body-preview"); const readMoreSection = article.querySelector(".read-more-background"); // Hide summary and read-more section summary.style.display = "none"; readMoreSection.style.display = "none"; // Show the full article body body.classList.remove("hidden"); } document.addEventListener("DOMContentLoaded", () => { let loadCount = 0; // Track how many times articles are loaded const offset = [1, 2, 3, 4, 5, 6, 7, 8, 9, 10]; // Offset values const currentUrl = window.location.pathname.substring(1); let isLoading = false; // Prevent multiple calls if (!currentUrl) { console.log("Current URL is invalid."); return; } const sentinel = document.getElementById("load-more-sentinel"); if (!sentinel) { console.log("Sentinel element not found."); return; } function isSentinelVisible() { const rect = sentinel.getBoundingClientRect(); return ( rect.top < window.innerHeight && rect.bottom >= 0 ); } function onScroll() { if (isLoading) return; if (isSentinelVisible()) { if (loadCount >= offset.length) { console.log("Maximum load attempts reached."); window.removeEventListener("scroll", onScroll); return; } isLoading = true; const currentOffset = offset[loadCount]; window.loadMoreItems().then(() => { let article = document.querySelector('#widget_1690 > div:nth-last-of-type(2) article'); intersectionObserver.observe(article) loadCount++; }).catch(error => { console.error("Error loading more items:", error); }).finally(() => { isLoading = false; }); } } window.addEventListener("scroll", onScroll); });

Sign up by email to receive news.